BridgeBio Pharma Inc (BBIO) — Defensive Interval Ratio
BridgeBio Pharma Inc (BBIO) has a Defensive Interval Ratio of 201 days as of September 2025. Defensive assets of $119.51 Million (cash $-, short-term investments $2.99 Million, receivables $116.52 Million) cover 201 days of daily cash needs of $593.42K/day. Check BridgeBio Pharma Inc (BBIO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BridgeBio Pharma Inc Defensive Interval Ratio (2019–2024)
This chart shows how BridgeBio Pharma Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 201 days, meaning defensive assets of $119.51 Million can fund 201 days of operations without new revenue. Also explore net asset growth rate of BridgeBio Pharma Inc to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for BridgeBio Pharma Inc (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for BridgeBio Pharma Inc from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BBIO market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 11 days | $4.72 Million | $423.01K/day | $- | $0.00 | ▼ -143 days |
| 2023 | 154 days | $60.70 Million | $394.09K/day | $- | $58.95 Million | ▼ -184 days |
| 2022 | 338 days | $112.31 Million | $332.68K/day | $- | $95.23 Million | ▼ -913 days |
| 2021 | 1250 days | $462.64 Million | $370.05K/day | $- | $442.89 Million | ▲ +292 days |
| 2020 | 958 days | $251.01 Million | $262.05K/day | $- | $251.01 Million | ▼ -161 days |
| 2019 | 1119 days | $185.06 Million | $165.44K/day | $- | $182.22 Million | — |